Metabolic activation of 9-hydroxymethyl-10-methylanthracene and 1-hydroxymethylpyrene to electrophilic, mutagenic and tumorigenic sulfuric acid esters by rat hepatic sulfotransferase activity
- 31 December 1989
- journal article
- research article
- Published by Oxford University Press (OUP) in Carcinogenesis: Integrative Cancer Research
- Vol. 11 (9), 1451-1460
- https://doi.org/10.1093/carcin/11.9.1451
Abstract
Our previous studies on 7-hydroxymethyl-12-methylbenz[.alpha.]anthracene and 6-hydroxymethylbenzo[.alpha.]pyrene showed that cytosolic sulfotransferase activity plays a major role in the formation of hepatic benzylic DNA and RNA adducts by these carcinogens in rats. In the present study, we found similar sulfotransferase activity in rat liver cytosol which activates 9-hydroxymethyl-10-methylanthracene (HMA) and 1-hydroxymethylpyrene (HMP) to electrophilic sulfuric acid ester metabolites. Thus, incubation of these non-bay region hydrocarbons with calf thymus DNA in the presence of liver cytosol fortified with the sulfo-group donor, 3''-phosphoadenosine-5''-phosphosulfate (PAPS) produced benzylic DNA adducts that were chromatographically identical to those obtained by the reactions of the corresponding sulfuric acid esters with deoxyguanosine and deoxyadenosine. These adducts were also produced in the livers of infant rats injected i.p. with 0.25 .mu.mol/g body wt of HMA or HMP. Administration of comparable doses of 9-sulfooxymethyl-10-methylanthracene (SMA) and 1-sulfooxymethylpyrene (SMP) resulted in much higher levels of hepatic benzylic DNA adducts than did the parent hydroxymethyl hydrocarbons. Both HMA and HMP induced His+ revertants in Salmonella typhimurium TA98 when preincubated with these bacteria in the presence of rat liver cytosol and PAPS. This sulfotransferase-mediated mutagenicity of HMA and HMP was reduced dehydroepiandrosterone, an inhibitor of hepatic sulfotransferase activity for these hydrocarbons. SMA and SMP were directly mutagenic and their intrinsic bacterial mutagenicity was inhibited by glutathione (GSH) and GSH-S-transferase activity. Chloride ion at physiological concentrations enhanced the bacterial mutagenicity of SMA through the formation of 9-chloromethyl-10-methylanthracene as previously observed for SMP by Henschler et al. In contrast to the higher mutagenicity of 1-chloromethylpyrene (CMP) than SMP in bacteria, CMP formed smaller amounts of hepatic benzylic DNA adducts in rats than the sulfuric acid ester. SMA and SMP were weak skin tumor initiators in the mouse, but they were more active than HMA and HMP in this regard.This publication has 26 references indexed in Scilit:
- A hydroxysteroid sulfotransferase from rat liverAnalytical Biochemistry, 1980
- Non-enzymatic ATP-mediated binding of hydroxymethyl derivatives of aromatic hydrocarbons to DNAChemico-Biological Interactions, 1980
- The identity of alcohol sulfotransferases with hydroxysteroid sulfotransferasesArchives of Biochemistry and Biophysics, 1980
- Identification of 7,12-dimethylbenz[ a ]anthracene metabolites that lead to mutagenesis in mammalian cellsProceedings of the National Academy of Sciences, 1979
- Metabolism of [14C]phenol by sheep, pig and ratXenobiotica, 1979
- Biochemical significance of the hard and soft acids and bases principleChemico-Biological Interactions, 1978
- MECHANISM OF INVITRO MUTAGENIC ACTIVATION AND COVALENT BINDING OF N-HYDROXY-2-ACETYLAMINOFLUORENE IN ISOLATED LIVER-CELL NUCLEI FROM RAT AND MOUSE1978
- Studies on the mutagenicity of N-hydroxy-2-acetylaminofluorene in the ames-salmonella mutagenesis test systemBiochemical Pharmacology, 1978
- Phenol sulphotransferase and uridine diphosphate glucuronyltransferase from rat liver in vivo and in vitro. 2,6-Dichloro-4-nitrophenol as selective inhibitor of sulphationBiochemical Journal, 1977
- Enzyme-Catalyzed Reactions of the Carcinogen N -Hydroxy-2-fluorenylacetamide with Nucleic AcidScience, 1968